2023 Rheumatology Grand Rounds

Occurs monthly on the 4th Tuesday starting on 1/24/2023 at 8:00 AM
Tuesday, January 24, 2023, 8:00 AM - 9:00 AM, Cedars-Sinai Medical Center, Los Angeles, CA


The Rheumatology Grand Rounds is designed to provide physicians and health care practitioners including those that provide primary care to their patients with up-to-date information on how to recognize, diagnose, treat, and follow rheumatologic conditions. This activity will emphasize early diagnosis, identification of risk factors for prognosis, intervention early rather than later, and recognition of side effects or toxicities related to treatment strategies. In addition to the very practical aspects of patient diagnosis and management, we will provide speakers who will address the pathogenesis and genetic risk for chronic rheumatic diseases as well as identify the comorbidities that accompany our diseases. Most importantly these lecture topics will address pathologic mechanisms of disease that form the basis not only for disease recognition in the earliest stages but also provide insights into mechanisms of damage and the possibilities of disease prevention. This series is intended for Cedars-Sinai healthcare professionals.

1. Differentiate psoriasis from other diseases after patient evaluation and recognize the comorbidities associated with it. Understand new approaches to diagnosis and treatment.
2. Understand underlying processes contributing to development of osteoporosis and the integration of new therapeutics into patient care.
3. Identify arthritis and rheumatic diseases in their early stages with the possibility of treating reversible aspects and preventing damage long term.
4. Manage the pain of rheumatic diseases taking into consideration co-morbidities of the patients, risks of drug treatments and their side effects, and the use of non-drug strategies when appropriate.
5. Implement strategies of disease management by identifying genetic and biomarkers of disease prognosis that will predict both long and short-term outcomes. Evaluate strategies for identifying markers of disease susceptibility; both genetic and environmental, that will incorporate the best practices into the clinical care of patients with joint complaints.

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

For activity access and session related questions, please contact
     Emails: [email protected]; [email protected]


For general CME questions, please contact 
     Email: [email protected] 

AMA PRA Category 1 Credit(s)™ (MD, DO) (1.00 hours), Non-Physician AMA Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.